Anhui Hongyu Wuzhou Medical Device Co., Ltd. Board of Directors
Statement on Compliance with Article 4 of the "Regulatory Guidelines for Listed Companies No. 9 — Regulatory Requirements for Planning and Implementing Major Asset Restructuring"
301234SZSE
🚨 Material Event
Board of Directors' Statement on Compliance with Article 4 of Regulatory Guidelines No. 9 for Major Asset Restructuring
✨ AI Summary
The Board of Directors of Anhui Hongyu Wuzhou Medical Device Co., Ltd. confirms that the proposed acquisition of 100% equity in Xuanzhi Electronic Technology (Shanghai) Co., Ltd. complies with regulatory requirements. The transaction is expected to enhance asset quality and operational capabilities without adverse financial impact or compromising independence.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· gemini_document
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.